Editorial Board for section 'AI in Drug Development'
- Medicinal Chemistry Section
- Biopharmaceuticals Section
- Natural Products Section
- Radiopharmaceutical Sciences Section
- Pharmacology Section
- Pharmaceutical Technology Section
- AI in Drug Development Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Department of Chemistry and Center for Advanced Computational Molecular Science, University of Colorado Denver, Campus Box 194, P.O. Box 173364, Denver, CO 80217, USA
Interests: reliable AI for molecular science and chemical education; AI/ML for drug research, photochemistry, and nanomaterials
* Section: AI in Drug Development
Special Issues, Collections and Topics in MDPI journals
Interests: reliable AI for molecular science and chemical education; AI/ML for drug research, photochemistry, and nanomaterials
* Section: AI in Drug Development
Special Issues, Collections and Topics in MDPI journals
Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria
Interests: drug design; molecular docking; molecular dynamics; hydrazones; anticancer activity; structure–activity relations
Special Issues, Collections and Topics in MDPI journals
Interests: drug design; molecular docking; molecular dynamics; hydrazones; anticancer activity; structure–activity relations
Special Issues, Collections and Topics in MDPI journals
Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
Interests: host defense antimicrobial peptides; structural bioinformatics; biomolecular NMR
Special Issues, Collections and Topics in MDPI journals
Interests: host defense antimicrobial peptides; structural bioinformatics; biomolecular NMR
Special Issues, Collections and Topics in MDPI journals
